Exact Sciences Awards Grants to 23 Organizations Focused on Increasing Colorectal Cancer Screenings
Grant recipients are committed to improving colorectal cancer (CRC) screening rates and making healthcare more accessible, with a focus on medically underserved populations.
- Grant recipients are committed to improving colorectal cancer (CRC) screening rates and making healthcare more accessible, with a focus on medically underserved populations.
- Exact Sciences' FOCUS Program provides grant funding to community organizations, health foundations, public health organizations, and advocacy groups working to increase access to CRC screening.
- Exact Sciences developed Cologuard®, the first and only FDA-approved, noninvasive, multi-target, stool-based DNA screening test that people can use at home.
- Since making the test available in 2014, Exact Sciences has delivered more than 13 million Cologuard results to patients.